# Effect of Pharmacogenetics on Imatinib Plasma Level and Response

> **NCT03262974** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 60 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** PCR
- **DIAGNOSTIC_TEST:** HPLC-UV

## Key facts

- **NCT ID:** NCT03262974
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-29
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262974, "Effect of Pharmacogenetics on Imatinib Plasma Level and Response". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03262974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*